KCa channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549)

Felix Glaser(University of Münster), Albrecht Schwab(University of Münster)
Scientific Reports
September 15, 2021
Cited by 25


Related Papers